|
|
Post by Thundersnow on May 10, 2023 9:54:02 GMT -5
I believe Mike will issue an offering to fund a new Manufacturing Facility. With the anticipated growth of DPI and the future approval of Pediatrics, INDIA and Clofazimine MNKD will have to increase capacity. Danbury is hitting their footprint limits and Mike has to think 3-5 years out.
One advantage is they can piggyback off of UTHR's experience in building a new facility from scratch. They also are taking note that UTHR is spending $500M to build it.
Mike is going to raise capital in the next 6-12 months with plans to increase production. Hopefully the stock price will be north of $15 and less shares will be used.
|
|
|
|
Post by akemp3000 on May 10, 2023 10:39:00 GMT -5
Everyone has a right to speculate but Mike made it clear with the current plant expansion plus UTHR's new plant, supply isn't likely going to be a problem even with UTHR's aggressive goals. IMO, it's more likely in the long run that UTHR will manufacture more and MNKD less which would free up the soon to be larger MNKD plant for the company's own future needs. It's also more likely UTHR is piggybacking off MNKD's experience in building a new Technosphere facility from scratch since they're the one who's already done it. I'm taking Mike at his word that having more shares on the shelf is just good business practice. If I were to speculate a future use for the shares, it would have something to do with M&A but that's just a wild guess since there's nothing to indicate anything is in the works.
|
|
|
|
Post by prcgorman2 on May 10, 2023 11:20:34 GMT -5
Interesting times. UTHR building a plant which makes TreT (Treprostinil TechnoSphere aka Tyvaso DPI). Anybody else wonder if the only thing UTHR wants to use a half-billion dollar plant for is to put Treprostinil on TechnoSphere? Dr. Rothblatt has proven to be exceedingly shrewd. The 400M share authorization request mentioned defense against a hostile take-over. Keep your friends close, and your enemies closer.
|
|
|
|
Post by agedhippie on May 10, 2023 17:00:52 GMT -5
Interesting times. UTHR building a plant which makes TreT (Treprostinil TechnoSphere aka Tyvaso DPI). Anybody else wonder if the only thing UTHR wants to use a half-billion dollar plant for is to put Treprostinil on TechnoSphere? Dr. Rothblatt has proven to be exceedingly shrewd. The 400M share authorization request mentioned defense against a hostile take-over. Keep your friends close, and your enemies closer. I think Martine is expecting Tyvaso-DPI to be applicable beyond just the current indications which is why UTHR are doing trials for other conditions. Even if it ends up as just the PH-ILD market that alone is huge. Given the size of the market UTHR is going to want to be the primary manufacturer simply for cost reasons. It's not going to be a quick build though so I expect it to be a couple of years out at the earliest and likely longer. |
|
|
|
Post by Thundersnow on May 10, 2023 17:04:09 GMT -5
You never take the CEO at his word. How many times have CEO's make comments/statements and a few weeks later do the opposite. Yes Mike says AT THIS POINT IN TIME that they have no plans but that could change 24 hours from now.
There's no way UTHR is going to invest millions on Danbury and then reduce production. Danbury is going to run DPI for years which means MNKD will have to find more capacity.
Now MNKD could buy a company(s) that has a manufacturing facility with the extra shares.
We shall see.
|
|
|
|
Post by ktim on May 10, 2023 18:34:28 GMT -5
It's not inconceivable that the main purpose is to hold down the share price so that execs continue to be awarded low priced shares for a longer period. A bit cynical, though to the extent true would indicate a long term belief in increasing enterprise value of MNKD.
Not typical for me to indulge in wild speculation, but seems this thread is all about that, lol.
|
|
|
|
Post by cedafuntennis on May 10, 2023 18:34:31 GMT -5
Also, it takes many years for UT to build that production facility, have it certified and fully in production. MNKD has demand assured for as long as patients continue to have the product in such high demand. For MNKD to buy a production facility, would take them to the same position as UT where it will take years? Better expand the existing to the maximum as soon as humanly possible, and the rest will follow.
|
|
|
|
Post by phdedieu12 on May 10, 2023 20:55:10 GMT -5
It's not inconceivable that the main purpose is to hold down the share price so that execs continue to be awarded low priced shares for a longer period. A bit cynical, though to the extent true would indicate a long term belief in increasing enterprise value of MNKD. Not typical for me to indulge in wild speculation, but seems this thread is all about that, lol. Outside of the weekly scripts, arguably the whole board is about wild speculations LOL |
|
|
|
Post by porkini on May 10, 2023 23:06:26 GMT -5
It's not inconceivable that the main purpose is to hold down the share price so that execs continue to be awarded low priced shares for a longer period. A bit cynical, though to the extent true would indicate a long term belief in increasing enterprise value of MNKD. Not typical for me to indulge in wild speculation, but seems this thread is all about that, lol. Outside of the weekly scripts, arguably the whole board is about wild speculations LOL Good for you to have included "arguably." |
|
|
|
Post by letitride on May 11, 2023 0:30:44 GMT -5
I believe the extra shares are for future growth of the company. I think the potential of Afrezza has been beaten down so long everyone has forgotten how to look up. Patients do not say it changed my life because its just like every other meal time insulin out there. When Afrezza gets SOC Al Manns vision of the best selling drug out there is likely to come to fruition in my opinion and will dwarf everything we now know. 400 Million shares I voted yes.
|
|
|
|
Post by ktim on May 11, 2023 1:22:13 GMT -5
I believe the extra shares are for future growth of the company. I think the potential of Afrezza has been beaten down so long everyone has forgotten how to look up. Patients do not say it changed my life because its just like every other meal time insulin out there. When Afrezza gets SOC Al Manns vision of the best selling drug out there is likely to come to fruition in my opinion and will dwarf everything we now know. 400 Million shares I voted yes. Well, would be nice if he were to make that case rather than relying on people here reading between the lines to promote it. According to him it's for "housekeeping"... a $1.6B maid... maybe including some touch up paint in his office, lol |
|
|
|
Post by letitride on May 11, 2023 1:37:01 GMT -5
Afrezza is a beast could require alot of housekeepingš. MC has turned this around and is growing the company I trust him to continue to do so. If he is not putting everything on the table I trust its in the best interest of the company
|
|
|
|
Post by hellodolly on May 11, 2023 5:55:06 GMT -5
Afrezza is a beast could require alot of housekeepingš. MC has turned this around and is growing the company I trust him to continue to do so. If he is not putting everything on the table I trust its in the best interest of the company I believe you're actually thinking exactly as Mike. Could you imagine a world where suddenly there is an increased demand for Afrezza and MNKD doesn't have the capacity to manufacture it? Me thinks the SP would suffer, Mike's ability to think and plan ahead for an event like that would come into question and his job would be at risk all because he didn't have a backstop in place? Critics would question his "long-term" conviction in MNKDs flagship product. As it is, my bet is Tyvaso, DPI is already (or will be soon) putting pressure on manufacturing capabilities in Danbury and approval in India, eventual approval in pediatrics along with UTHR adding an additional drug into the manufacturing pipeline, could create a nightmare scenario. UTHR building another manufacturing facility will certainly help, especially after the 10 year agreement comes to an end as they transition into manufacturing Tyvaso, DPI on their own. Regardless, as has been mentioned, MNKD needs to look well ahead into the future. As Mike replied when asked about the increase in shares, [paraphrasing] "They don't have anything really planned but want to have it available if they need it" is really counterintuitive to how Mike thinks. I believe, as the CEO, he has plans for those shares on his mind...he just hasn't shared them yet. |
|
|
|
Post by letitride on May 11, 2023 7:19:52 GMT -5
And I keep thinking I need more shares to. Lets Go!
|
|
|
|
Post by Thundersnow on May 11, 2023 10:41:46 GMT -5
And I keep thinking I need more shares to. Lets Go! Itās evident from the CC UTHR is putting pressure on MNKD to increase their yield. Demand is through the roof and MNKD better step up. |
|
